Reduction of the rate of protein translation in patients with myotonic dystrophy 2

Claudia Huichalaf, Benedikt Schoser, Christiane Schneider-Gold, Bingwen Jin, Partha Sarkar, Lubov Timchenko

Research output: Contribution to journalArticle

59 Citations (Scopus)

Abstract

Myotonic dystrophy 2 (DM2) is an autosomal dominant, multisystem disease, which primarily affects skeletal muscle. DM2 is caused by CCTGn expansion in the intron 1 of the ZNF9 gene. Expression of the mutant CCUGn RNA changes RNA processing in patients with DM2; however, the role of ZNF9 protein in DM2 pathology has been not elucidated. ZNF9 has been shown to regulate cap-dependent and cap-independent translation. We have examined a possible role of ZNF9 in the regulation of translation in DM2 patients. We found that ZNF9 interacts with the 5' UTRs of terminal oligopyrimidine (TOP) tract mRNAs encoding human ribosomal protein, RPS17, poly(A)-binding protein 1 (PABP1), and the elongation factors, eEF1A and eEF2. The binding activity of ZNF9 toward these TOP-containing 5' UTRs is reduced in DM2 muscle. Consistent with the reduction of this activity, the levels of RPS17, PABP, eEF1A, and eEF2 proteins are also diminished in DM2 muscle. The reduction of ZNF9 RNA-binding activity in DM2 correlates with a decrease of ZNF9 protein levels in cytoplasm of DM2 muscle cells. We found that the reduction of ZNF9 is caused by expression of the mutant CCUG repeats. This decrease of proteins of translational apparatus in DM2 correlates with a reduction of a rate of protein synthesis in myoblasts from DM2 patients. We found that the ectopic expression of ZNF9 in DM2 myoblasts corrects rate of protein synthesis, suggesting that the alterations in CCUG-ZNF9-TOP mRNAs pathway are responsible for the reduction of the rate of protein translation in DM2 muscle cells.

Original languageEnglish (US)
Pages (from-to)9042-9049
Number of pages8
JournalJournal of Neuroscience
Volume29
Issue number28
DOIs
StatePublished - Jul 15 2009

Fingerprint

Myotonic Dystrophy
Protein Biosynthesis
Proteins
Myoblasts
5' Untranslated Regions
RNA
Muscle Cells
Poly(A)-Binding Proteins
Peptide Elongation Factor 1
Muscles
Messenger RNA
Ribosomal Proteins
Introns
Cytoplasm
Skeletal Muscle
Pathology
Genes

ASJC Scopus subject areas

  • Neuroscience(all)

Cite this

Reduction of the rate of protein translation in patients with myotonic dystrophy 2. / Huichalaf, Claudia; Schoser, Benedikt; Schneider-Gold, Christiane; Jin, Bingwen; Sarkar, Partha; Timchenko, Lubov.

In: Journal of Neuroscience, Vol. 29, No. 28, 15.07.2009, p. 9042-9049.

Research output: Contribution to journalArticle

Huichalaf, C, Schoser, B, Schneider-Gold, C, Jin, B, Sarkar, P & Timchenko, L 2009, 'Reduction of the rate of protein translation in patients with myotonic dystrophy 2', Journal of Neuroscience, vol. 29, no. 28, pp. 9042-9049. https://doi.org/10.1523/JNEUROSCI.1983-09.2009
Huichalaf, Claudia ; Schoser, Benedikt ; Schneider-Gold, Christiane ; Jin, Bingwen ; Sarkar, Partha ; Timchenko, Lubov. / Reduction of the rate of protein translation in patients with myotonic dystrophy 2. In: Journal of Neuroscience. 2009 ; Vol. 29, No. 28. pp. 9042-9049.
@article{52593291bc4e4320928aeb293649ec0b,
title = "Reduction of the rate of protein translation in patients with myotonic dystrophy 2",
abstract = "Myotonic dystrophy 2 (DM2) is an autosomal dominant, multisystem disease, which primarily affects skeletal muscle. DM2 is caused by CCTGn expansion in the intron 1 of the ZNF9 gene. Expression of the mutant CCUGn RNA changes RNA processing in patients with DM2; however, the role of ZNF9 protein in DM2 pathology has been not elucidated. ZNF9 has been shown to regulate cap-dependent and cap-independent translation. We have examined a possible role of ZNF9 in the regulation of translation in DM2 patients. We found that ZNF9 interacts with the 5' UTRs of terminal oligopyrimidine (TOP) tract mRNAs encoding human ribosomal protein, RPS17, poly(A)-binding protein 1 (PABP1), and the elongation factors, eEF1A and eEF2. The binding activity of ZNF9 toward these TOP-containing 5' UTRs is reduced in DM2 muscle. Consistent with the reduction of this activity, the levels of RPS17, PABP, eEF1A, and eEF2 proteins are also diminished in DM2 muscle. The reduction of ZNF9 RNA-binding activity in DM2 correlates with a decrease of ZNF9 protein levels in cytoplasm of DM2 muscle cells. We found that the reduction of ZNF9 is caused by expression of the mutant CCUG repeats. This decrease of proteins of translational apparatus in DM2 correlates with a reduction of a rate of protein synthesis in myoblasts from DM2 patients. We found that the ectopic expression of ZNF9 in DM2 myoblasts corrects rate of protein synthesis, suggesting that the alterations in CCUG-ZNF9-TOP mRNAs pathway are responsible for the reduction of the rate of protein translation in DM2 muscle cells.",
author = "Claudia Huichalaf and Benedikt Schoser and Christiane Schneider-Gold and Bingwen Jin and Partha Sarkar and Lubov Timchenko",
year = "2009",
month = "7",
day = "15",
doi = "10.1523/JNEUROSCI.1983-09.2009",
language = "English (US)",
volume = "29",
pages = "9042--9049",
journal = "Journal of Neuroscience",
issn = "0270-6474",
publisher = "Society for Neuroscience",
number = "28",

}

TY - JOUR

T1 - Reduction of the rate of protein translation in patients with myotonic dystrophy 2

AU - Huichalaf, Claudia

AU - Schoser, Benedikt

AU - Schneider-Gold, Christiane

AU - Jin, Bingwen

AU - Sarkar, Partha

AU - Timchenko, Lubov

PY - 2009/7/15

Y1 - 2009/7/15

N2 - Myotonic dystrophy 2 (DM2) is an autosomal dominant, multisystem disease, which primarily affects skeletal muscle. DM2 is caused by CCTGn expansion in the intron 1 of the ZNF9 gene. Expression of the mutant CCUGn RNA changes RNA processing in patients with DM2; however, the role of ZNF9 protein in DM2 pathology has been not elucidated. ZNF9 has been shown to regulate cap-dependent and cap-independent translation. We have examined a possible role of ZNF9 in the regulation of translation in DM2 patients. We found that ZNF9 interacts with the 5' UTRs of terminal oligopyrimidine (TOP) tract mRNAs encoding human ribosomal protein, RPS17, poly(A)-binding protein 1 (PABP1), and the elongation factors, eEF1A and eEF2. The binding activity of ZNF9 toward these TOP-containing 5' UTRs is reduced in DM2 muscle. Consistent with the reduction of this activity, the levels of RPS17, PABP, eEF1A, and eEF2 proteins are also diminished in DM2 muscle. The reduction of ZNF9 RNA-binding activity in DM2 correlates with a decrease of ZNF9 protein levels in cytoplasm of DM2 muscle cells. We found that the reduction of ZNF9 is caused by expression of the mutant CCUG repeats. This decrease of proteins of translational apparatus in DM2 correlates with a reduction of a rate of protein synthesis in myoblasts from DM2 patients. We found that the ectopic expression of ZNF9 in DM2 myoblasts corrects rate of protein synthesis, suggesting that the alterations in CCUG-ZNF9-TOP mRNAs pathway are responsible for the reduction of the rate of protein translation in DM2 muscle cells.

AB - Myotonic dystrophy 2 (DM2) is an autosomal dominant, multisystem disease, which primarily affects skeletal muscle. DM2 is caused by CCTGn expansion in the intron 1 of the ZNF9 gene. Expression of the mutant CCUGn RNA changes RNA processing in patients with DM2; however, the role of ZNF9 protein in DM2 pathology has been not elucidated. ZNF9 has been shown to regulate cap-dependent and cap-independent translation. We have examined a possible role of ZNF9 in the regulation of translation in DM2 patients. We found that ZNF9 interacts with the 5' UTRs of terminal oligopyrimidine (TOP) tract mRNAs encoding human ribosomal protein, RPS17, poly(A)-binding protein 1 (PABP1), and the elongation factors, eEF1A and eEF2. The binding activity of ZNF9 toward these TOP-containing 5' UTRs is reduced in DM2 muscle. Consistent with the reduction of this activity, the levels of RPS17, PABP, eEF1A, and eEF2 proteins are also diminished in DM2 muscle. The reduction of ZNF9 RNA-binding activity in DM2 correlates with a decrease of ZNF9 protein levels in cytoplasm of DM2 muscle cells. We found that the reduction of ZNF9 is caused by expression of the mutant CCUG repeats. This decrease of proteins of translational apparatus in DM2 correlates with a reduction of a rate of protein synthesis in myoblasts from DM2 patients. We found that the ectopic expression of ZNF9 in DM2 myoblasts corrects rate of protein synthesis, suggesting that the alterations in CCUG-ZNF9-TOP mRNAs pathway are responsible for the reduction of the rate of protein translation in DM2 muscle cells.

UR - http://www.scopus.com/inward/record.url?scp=67650742030&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=67650742030&partnerID=8YFLogxK

U2 - 10.1523/JNEUROSCI.1983-09.2009

DO - 10.1523/JNEUROSCI.1983-09.2009

M3 - Article

VL - 29

SP - 9042

EP - 9049

JO - Journal of Neuroscience

JF - Journal of Neuroscience

SN - 0270-6474

IS - 28

ER -